164 related articles for article (PubMed ID: 33173410)
21. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
[TBL] [Abstract][Full Text] [Related]
22. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
24. Integrated bioinformatic analysis of HNF1A in human cancers.
Zhang E; Huang X; He J
J Int Med Res; 2021 Mar; 49(3):300060521997326. PubMed ID: 33752475
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in
Li Z; Lin J; Zhang L; Li J; Zhang Y; Zhao C; Wang H
Future Oncol; 2020 Oct; 16(29):2295-2306. PubMed ID: 32639175
[No Abstract] [Full Text] [Related]
26. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
27. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Liu J; Chen Z; Zhao P; Li W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648580
[TBL] [Abstract][Full Text] [Related]
29. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Complement Properdin in Cancer.
Mangogna A; Varghese PM; Agostinis C; Alrokayan SH; Khan HA; Stover CM; Belmonte B; Martorana A; Ricci G; Bulla R; Kishore U
Front Immunol; 2020; 11():614980. PubMed ID: 33542722
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract][Full Text] [Related]
32. Survival Genie, a web platform for survival analysis across pediatric and adult cancers.
Dwivedi B; Mumme H; Satpathy S; Bhasin SS; Bhasin M
Sci Rep; 2022 Feb; 12(1):3069. PubMed ID: 35197510
[TBL] [Abstract][Full Text] [Related]
33. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
[TBL] [Abstract][Full Text] [Related]
34. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer.
Luo C; Chen J; Chen L
Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155
[TBL] [Abstract][Full Text] [Related]
35. A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma.
Yu H; Zhu X; Lin H; Pan H; Zhao F; Zhu M; Sun L; Chai W; Yao M; Yan M
Aging (Albany NY); 2020 Jun; 12(12):12234-12250. PubMed ID: 32564007
[TBL] [Abstract][Full Text] [Related]
36. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
37. Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression.
Yamasaki H; Sada A; Iwata T; Niwa T; Tomizawa M; Xanthopoulos KG; Koike T; Shiojiri N
Development; 2006 Nov; 133(21):4233-43. PubMed ID: 17021047
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations.
Oram RA; Edghill EL; Blackman J; Taylor MJ; Kay T; Flanagan SE; Ismail-Pratt I; Creighton SM; Ellard S; Hattersley AT; Bingham C
Am J Obstet Gynecol; 2010 Oct; 203(4):364.e1-5. PubMed ID: 20633866
[TBL] [Abstract][Full Text] [Related]
39. Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases.
Chen MN; Zeng D; Zheng ZQ; Li Z; Wu JL; Jin JY; Wang HJ; Huang CZ; Lin HY
J Vis Exp; 2019 May; (147):. PubMed ID: 31157790
[TBL] [Abstract][Full Text] [Related]
40. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
